IONS IONS
Company Profile ↓Company Overview
IONS (IONS) is a publicly traded company listed on with a market capitalization of $8.85B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Revenue has grown at a 13.7% CAGR over the past five years.
Recent Developments
- Dec 2025 Revenue of $943.71M (+33.8% YoY); net profit $-381.39M.
- Trailing 12 Months Year-on-year growth — revenue +33.8%.
- 5-Year Trend Long-term compounding — revenue CAGR 13.7%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 13.65% |
| 1 Year: | 33.83% |
Stock Price Performance
| 1 Year: | +24.72% |
| 6 Months: | -35.94% |
| 3 Months: | -27.99% |
| 1 Month: | -37.23% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)35.13 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 13.7% over 5 years.
CONS
- Trading 37.4% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | 115.80M | 112.27M | 118.31M | - | 144.42M | 117.75M | 145.40M | - | 297.21M | 163.81M | 167.89M | - | 133.37M | 145.54M | 160.08M | - | 111.61M | 125.75M | 133.09M | - | 141.92M | 133.79M | 159.77M | - | 130.52M | 188.41M | 144.21M | - | 119.50M | 225.25M | 133.81M | - | 131.61M | 452.05M | 156.72M | - | 246.09M | 267.95M |
| Operating Income | 16.11M | 41.16M | 19.48M | 6.45M | 11.31M | -6.20M | -3.30M | -50.28M | -18.57M | 10.78M | 121.53M | -18.83M | 2.52M | 260.65M | -61.13M | -51.75M | -36.54M | -22.66M | -91.97M | -72.97M | -85.85M | 220.60M | -57.50M | -85.51M | -59.15M | -208.02M | -114.15M | -90.19M | -143.26M | -6.12M | -149.51M | -66.09M | -148.66M | -110.82M | -146.86M | 139.82M | -160.18M | -214.46M | -117.42M | -102.29M |
| Net Income | 7.35M | 25.86M | 8.96M | -3.08M | -2.61M | -2.92M | -1.42M | -40.36M | -4.56M | 320.08M | 84.44M | -876.00K | 26.16M | 184.41M | -39.63M | -25.64M | -24.47M | -354.53M | -89.87M | -80.88M | -82.47M | 224.61M | -65.17M | -105.14M | -46.99M | -52.43M | -124.32M | -85.29M | -147.41M | -9.26M | -142.80M | -66.27M | -140.48M | -104.35M | -146.94M | 123.55M | -128.61M | -229.39M | -92.53M | -114.65M |
| Diluted EPS | 0.06 | 0.21 | 0.07 | -0.02 | -0.02 | -0.03 | -0.01 | -0.29 | -0.03 | 2.21 | 0.62 | -0.01 | 0.18 | 1.28 | -0.28 | -0.18 | -0.18 | -2.54 | -0.64 | -0.57 | -0.58 | 1.41 | -0.46 | -0.74 | -0.33 | -0.37 | -0.87 | -0.60 | -1.03 | -0.06 | -0.98 | -0.45 | -0.95 | -0.66 | -0.93 | 0.70 | -0.80 | -1.41 | -0.56 | -0.69 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 107.19M | 121.60M | 108.47M | 99.09M | 102.05M | 147.28M | 214.16M | 283.70M | 372.78M | 514.18M | 599.67M | 1.12B | 729.26M | 810.46M | 587.37M | 787.65M | 705.14M | 943.71M |
| Operating Income | -13.06M | -27.54M | -48.36M | -71.10M | -68.92M | -51.67M | -47.73M | -75.76M | -20.16M | 31.05M | -61.37M | 365.88M | -172.08M | -30.19M | -410.19M | -353.73M | -475.08M | -381.68M |
| Net Income | -18.17M | 155.07M | -61.25M | -84.80M | -65.48M | -60.64M | -38.98M | -88.28M | -60.40M | 346.00K | 273.74M | 278.14M | -444.26M | -28.60M | -269.72M | -366.29M | -453.90M | -381.39M |
| Diluted EPS | -0.19 | 1.58 | -0.62 | -0.85 | - | - | - | -0.74 | -0.50 | 0.15 | 2.07 | 1.90 | -3.18 | -0.20 | -1.90 | -2.56 | -3.04 | -2.38 |
| R&D Expense | 106.44M | 134.62M | 145.16M | 153.10M | 154.60M | 173.70M | 238.90M | 319.50M | 340.40M | 372.50M | 411.90M | 461.50M | 531.00M | 638.20M | - | 899.62M | 901.53M | 915.62M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2007 | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 657.18M | 550.48M | 484.89M | 545.69M | 847.16M | 955.81M | 947.90M | 912.47M | 1.32B | 2.67B | 3.23B | 2.39B | - | 2.53B | 2.99B | 3.00B | 3.52B |
| Current Assets | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.20B | 2.64B | 2.62B | 2.99B |
| Cash & Equivalents | 138.61M | 223.99M | 105.25M | 70.05M | 65.48M | 124.48M | 159.97M | 143.00M | 128.80M | 84.69M | 129.63M | 278.82M | 683.29M | 397.66M | - | 276.47M | 399.27M | 242.08M | 372.26M |
| Inventory | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 22.03M | 7.44M | 12.51M | 10.05M |
| Receivables | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 25.54M | 97.78M | 92.19M | 66.06M |
| Total Liabilities | - | - | 355.12M | 305.94M | 313.46M | 362.92M | 468.77M | 698.03M | 747.11M | 812.90M | 957.49M | 1.48B | 1.55B | 1.65B | - | 1.96B | 2.60B | 2.42B | 3.03B |
| Current Liabilities | - | - | 111.44M | 105.89M | 76.11M | 74.32M | 97.81M | 115.33M | 148.88M | 133.78M | 243.61M | 280.29M | 273.00M | 598.90M | - | 311.56M | 448.09M | 309.32M | 781.57M |
| Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.18B | 1.23B | 1.25B | 1.35B |
| Total Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.37B | 1.45B | 1.42B | 2.06B |
| Total Equity | 59.59M | 147.38M | 291.72M | 244.54M | 171.43M | 182.77M | 378.39M | 257.78M | 200.79M | 99.56M | 281.01M | 1.05B | 1.47B | 743.28M | - | 572.89M | 386.69M | 588.35M | 489.09M |
| Shares Outstanding | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 142.06M | 144.34M | 157.91M | 163.30M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 212.03M | -108.44M | -63.59M | -114.80M | - | - | - | 21.12M | -112.11M | 174.15M | 602.91M | 345.63M | 35.89M | 30.80M | -274.37M | -307.51M | -500.95M | -268.58M |
| Investing Cash Flow | -234.25M | -212.29M | 23.69M | 110.90M | - | - | - | -60.05M | 56.60M | -358.29M | -929.56M | -41.27M | 274.48M | 194.91M | -262.64M | -214.13M | -134.03M | -277.78M |
| Financing Cash Flow | 107.58M | 202.00M | 4.70M | -672.00K | - | - | - | 24.73M | 11.39M | 229.09M | 475.87M | 100.02M | -596.61M | 245.93M | -55.30M | 644.08M | 478.06M | 675.84M |
| Capital Expenditure | -13.66M | -13.41M | -13.24M | -10.20M | -1.48M | -1.55M | -7.52M | -7.69M | -7.11M | -34.76M | -13.61M | -30.91M | -35.12M | -11.96M | -15.72M | -23.80M | -45.28M | -51.44M |
| Free Cash Flow | 198.37M | -121.86M | -76.83M | -125.00M | - | - | - | 13.43M | -119.21M | 139.38M | 589.30M | 314.72M | 772.00K | 18.84M | -290.09M | -331.32M | -546.23M | -320.03M |
| Share Buybacks | - | - | - | - | - | - | - | - | - | 0 | 0 | 34.40M | 90.55M | 0 | 0 | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Dec 2008 | Dec 2009 | Dec 2010 | Dec 2011 | Dec 2012 | Dec 2013 | Dec 2014 | Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Margin % | -12.2% | -22.6% | -44.6% | -71.8% | -67.5% | -35.1% | -22.3% | -26.7% | -5.4% | 6.0% | -10.2% | 32.6% | -23.6% | -3.7% | -69.8% | -44.9% | -67.4% | -40.4% |
| Net Margin % | -17.0% | 127.5% | -56.5% | -85.6% | -64.2% | -41.2% | -18.2% | -31.1% | -16.2% | 0.1% | 45.6% | 24.8% | -60.9% | -3.5% | -45.9% | -46.5% | -64.4% | -40.4% |
| ROE % | -12.3% | 53.2% | -25.0% | -49.5% | -35.8% | -16.0% | -15.1% | -44.0% | -60.7% | 0.1% | 26.1% | 18.9% | -59.8% | - | -47.1% | -94.7% | -77.1% | -78.0% |
| ROCE % | - | -5.0% | -10.9% | -17.4% | -14.6% | -6.9% | -5.7% | -9.5% | -2.6% | 2.9% | -2.6% | 12.4% | -9.6% | - | -18.5% | -13.9% | -17.6% | -13.9% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for IONS
IONS Stock Heads Toward Biggest Single-Day Slump In Over 5 Years – Retail Calls It ‘Opportunity Of A Lifetime’ - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxQeG9CdklqbEhhbTlBVDIwdDIzM05PMTB3VkFCQkxGc1l6c2Q1Q18tdnh1MFVmQzgtd3hhUnJpN1FLaEp2YmZTQ2IxRElKLWpnSHBWZ0Y5aG1zRld2ZkFhNDZ0ei1WZnotNmxxdEtvVVk1YUQ5UTBaUy1renhFT3Q1VUhEYkVZMlV2NlZpTG…
Ionic Digital (IOND) Stock Trends and Sentiment 2026 - MarketBeat
<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTE1EWUR0Z2VDMzRRbm1jUFBsZnlSY3ZIWExyYzhWV3hCcFprX2F0QXRjZEV3MVdZNHpaSEk4MGpyR25vZnptbmxCOEkzb1JiM3B5VzhxaGJPbERWUlF6MjVqNjU3cmdobEIzU0tQdXAybVZWeVFCclE?oc=5" target="_blank">Ionic Di…
Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Exploring a 72% Potential Upside Amidst Challenging Metrics - DirectorsTalk Interviews
<a href="https://news.google.com/rss/articles/CBMi6wFBVV95cUxOcTIxcV9jS3Zqbm00NDhYVFVyd0pGenJBUXhGT3hzRDRGVDZ4QWRWZWV4TkhBbnBHMXNjcHZMUUMwVTM2ZnNNOEhLdVFnQ05FWE1hU0hMZE5tY2R2cXY3TGhSTGpWQU5nYkZxbFlVU0RYZjVBYlppTmpYcjRDZ0s1dXZWUW9fbjR0NDNWVj…
Ionis Pharmaceuticals, Inc. (IONS) Faces Investor Scrutiny After Surprise Trial Failure Drives Stock Down 23% - HBSS - PR Newswire
<a href="https://news.google.com/rss/articles/CBMi-gFBVV95cUxPWHpJMUZTVnNGZmp0NVR3YW5qSEJWOGdBdXFWa1JFaGs5amQ3Q3JxbTJHOUItNjBET1RSbjA1aUhSUVd0bGFOUUdRNjhCU1dPM2NhbDRoYzJ0WU0yWEZOcTRGTGozblFaQURTUlE0UE1hNi04RWdrVjZCOUhvS1YtYUNpZk9oR0NIRmlMNW…
Ionis Pharmaceuticals (IONS) Stock Slips As Revenue Drops And Losses Return - simplywall.st
<a href="https://news.google.com/rss/articles/CBMi6gFBVV95cUxPRmpRNTlHUU5JenFwa19CMXpvU0ZfYnJ2ZDYtQUVYT2VxLVNOQm5CVm9XNWlVZUFyY3JoVXZXaFVfa1dKQ2t0dmdJcHRWV2FaTnBmeC1xNzl1RGFrZ0NOalpQNElpN3lMUWdsN0J6WkhJbGJLV1ZTZ2g0UTJOZ1FRUDAyLXFBWmwwYnZhS3…
Insider Purchase: Director at $IONS Buys 5,000 Shares - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxQd01BdHJ3UGZEUHhhNGZoWWlhRkRxX3lHNjYyWTczWkhlU19VclRwdm1RY2t0WlVYM3UwWkNHRThORDdOQVRha3doWjBtOTI4OTIwOHhTNUhoeklsZDVwcG40RXJiVV9UaE15YzI4Mno2cXQwV1EzVXF5SmxyRXhRR0VqQmlIdDQxUDhnYW…
IONS — Frequently Asked Questions
What is the current share price of IONS?
As of 2026-08-05 17:25 PDT, IONS trades at $54.19 on NASDAQ/NYSE. Its 52-week range is $40.69 to $86.50.
What is the market capitalisation of IONS?
IONS has a market capitalisation of $8.85B on NASDAQ/NYSE.
What is the P/E ratio of IONS?
IONS trades at a trailing price-to-earnings (P/E) ratio of -22.77. Its price-to-book (P/B) ratio is 18.09.
What is the return on equity (ROE) of IONS?
IONS has a return on equity (ROE) of -77.98%. Its return on capital employed (ROCE) is -13.92%.
Is IONS a good stock to buy?
This page provides a data-driven analysis of IONS, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.